Bradley D. Stein

MedicinePsychologyEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Listings of Buprenorphine Offering by Substance Use Disorder Treatment Facilities and Waivered Clinician From July 2019 to May 2021

Journal of Addiction Medicine(2025)10.1097/adm.0000000000001439

Top 100%

0DataRank

Top 100%0 citations

Erin Audrey Taylor, Bradley D. Stein, Yuji Mizushima, Denis Agniel, Jonathan Cantor +1 more

Papers

Driven by 41 papers — median percentile 0. Top paper: “Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes”.

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.14328

N/A

0.483DataRank · unranked

24 citations

Jonathan Cantor, Ashley C. Bradford, Kosali Simon, Bradley D. Stein, Erin Audrey Taylor

Multiplying the Impact of Opioid Settlement Funds by Investing in Primary Prevention

Journal of Hospital Medicine(2020)10.12788/jhm.3455

N/A

0DataRank · unranked

6 citations

Scott E. Hadland, Bradley D. Stein, Stephen W. Patrick, Laura J. Faherty

Variation in Performance of Commonly Used Statistical Methods for Estimating Effectiveness of State-Level Opioid Policies on Opioid-Related Mortality

National Bureau of Economic Research(2020)10.3386/w27029

N/A

0DataRank · unranked

3 citations

Megan S. Schuler, Elizabeth A. Stuart, Stephen W. Patrick, Elizabeth McNeer, Rosanna Smart +5 more

2020 trends in dental office visits during the COVID-19 pandemic

The Journal of the American Dental Association(2021)10.1016/j.adaj.2021.02.016

N/A

0DataRank · unranked

74 citations

Annie Chen, Grace Gahlon, Bradley D. Stein, Ashley M. Kranz

Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US

JAMA(2021)10.1001/jama.2021.4469

N/A

0DataRank · unranked

55 citations

Brendan Saloner, Megan S. Schuler, Jill Gurvey, Mark Sorbero, Adam J. Gordon +1 more

Longitudinal effects of adverse childhood experiences on substance use transition patterns during young adulthood

Child Abuse & Neglect(2021)10.1016/j.chiabu.2021.105201

N/A

0DataRank · unranked

46 citations

Joan S. Tucker, Bradley D. Stein, Elizabeth J. D’Amico, Jordan P. Davis

Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: a Retrospective Analysis

Journal of General Internal Medicine(2021)10.1007/s11606-020-06577-5

N/A

0DataRank · unranked

29 citations

Rosanna Smart, Christopher M. Jones, Flora Sheng, David Powell, Mark Sorbero +1 more

Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors

Journal of General Internal Medicine(2021)10.1007/s11606-021-07119-3

N/A

0DataRank · unranked

27 citations

Tisamarie B. Sherry, Brenna O’Neill, Erin Audrey Taylor, Mark Sorbero, Bradley D. Stein

Moving beyond the classic difference-in-differences model: a simulation study comparing statistical methods for estimating effectiveness of state-level policies

BMC Medical Research Methodology(2021)10.1186/s12874-021-01471-y

N/A

0DataRank · unranked

26 citations

Megan S. Schuler, Elizabeth A. Stuart, Stephen W. Patrick, Elizabeth McNeer, Rosanna Smart +5 more

The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic

Drug and Alcohol Dependence(2021)10.1016/j.drugalcdep.2021.109232

N/A

0DataRank · unranked

26 citations

Flora Sheng, Erin Audrey Taylor, Andrew W. Dick, Mark Sorbero, Rosalie Liccardo Pacula +1 more

Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic

Journal of Substance Abuse Treatment(2021)10.1016/j.jsat.2021.108384

N/A

0DataRank · unranked

19 citations

Andrew W. Dick, Rebecca L. Haffajee, Megan F. Pera, Dena M Bravata, Bradley D. Stein +2 more

Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories

Drug and Alcohol Dependence(2021)10.1016/j.drugalcdep.2021.109089

N/A

0DataRank · unranked

18 citations

Beth Ann Griffin, Brendan Saloner, Adam J. Gordon, Rose Kerber, Bradley D. Stein +1 more

Trends in visits to substance use disorder treatment facilities in 2020

Journal of Substance Abuse Treatment(2021)10.1016/j.jsat.2021.108462

N/A

0DataRank · unranked

14 citations

David W. Kravitz, Mark Sorbero, Barbara Andraka‐Christou, Christopher Whaley, Kathryn Bouskill +2 more

Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing

Journal of Substance Abuse Treatment(2022)10.1016/j.jsat.2021.108715

N/A

0DataRank · unranked

19 citations

Adam J. Gordon, Joanne Spetz, Rachel Totaram, Matthew Golan, Olivia Randall-Kosich +5 more

Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C

The American Journal of Drug and Alcohol Abuse(2022)10.1080/00952990.2022.2082301

N/A

0DataRank · unranked

18 citations

Brendan Saloner, Adam J. Gordon, Rachel Totaram, Olivia Randall-Kosich, Matthew Golan +2 more

Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder

JAMA Health Forum(2022)10.1001/jamahealthforum.2022.3285

N/A

0DataRank · unranked

18 citations

Sean Grant, Adam J. Gordon, Rosalie Liccardo Pacula, Bradley D. Stein, Rosanna Smart

Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.32795

N/A

0DataRank · unranked

15 citations

Christopher Whaley, Bradley D. Stein, David Powell, Jonathan Cantor

Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies

Drug and Alcohol Dependence(2022)10.1016/j.drugalcdep.2022.109669

N/A

0DataRank · unranked

14 citations

Isaac Opper, Brendan Saloner, Adam J. Gordon, Douglas Leslie, Mark Sorbero +2 more

Methodological considerations for estimating policy effects in the context of co-occurring policies

Health Services and Outcomes Research Methodology(2022)10.1007/s10742-022-00284-w

N/A

0DataRank · unranked

13 citations

Megan S. Schuler, Joseph Pane, Stephen W. Patrick, Rosanna Smart, Bradley D. Stein +3 more

A national survey of state laws regarding medications for opioid use disorder in problem-solving courts

Health & Justice(2022)10.1186/s40352-022-00178-6

N/A

0DataRank · unranked

10 citations

Olivia Randall-Kosich, Matthew Golan, Rachel Totaram, Brendan Saloner, Adam J. Gordon +2 more

Systematic Identification and Categorization of Opioid Prescribing and Dispensing Policies in 16 States and Washington, DC

Pain Medicine(2022)10.1093/pm/pnac124

N/A

0DataRank · unranked

3 citations

Elizabeth McAvoy, Maggie Ohama, Rosanna Smart, Mary E. Vaiana, Erin Audrey Taylor +2 more

Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety

Addiction(2023)10.1111/add.16180

N/A

0DataRank · unranked

22 citations

Penn Whitley, Eric Dawson, Steven D. Passik, Adam J. Gordon, Bradley D. Stein +1 more

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019

Annals of Medicine(2023)10.1080/07853890.2023.2171107

N/A

0DataRank · unranked

20 citations

Olivia K. Golan, Rachel Totaram, Maggie Ohama, Brendan Saloner, Adam J. Gordon +2 more

Mental Health Outcomes Among Patients Living in US Counties Lacking Broadband Access and Psychiatrists

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.33781

N/A

0DataRank · unranked

14 citations

Ryan K. McBain, Jonathan Cantor, Bradley D. Stein, Hao Yu, Tarun Ramesh

Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022

Pain Medicine(2023)10.1093/pm/pnad103

N/A

0DataRank · unranked

2 citations

Elizabeth McAvoy, Adam J. Gordon, Maggie Ohama, Marilyn Brach, Erin Audrey Taylor +4 more

County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder

Medical Care(2023)10.1097/mlr.0000000000001867

N/A

0DataRank · unranked

2 citations

Elizabeth McNeer, Bradley D. Stein, Michael R. Richards, Tamarra McElroy, William D. Dupont +2 more

Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act

Substance Abuse(2023)10.1177/08897077231186212

N/A

0DataRank · unranked

25 citations

Barbara Andraka‐Christou, Bradley D. Stein, Adam J. Gordon, Brendan Saloner

Identifying Optimal Methods for Addressing Confounding Bias When Estimating the Effects of State-Level Policies

arXiv (Cornell University)(2023)10.48550/arxiv.2307.01413

N/A

0DataRank · unranked

0 citations

Megan S. Schuler, Elizabeth M. Stone, Stephen W. Patrick, Bradley D. Stein, Pedro Nascimento de Lima +4 more

State paid sick leave mandates associated with increased mental health disorder prescriptions among Medicaid enrollees

Health Affairs Scholar(2024)10.1093/haschl/qxae045

N/A

0DataRank · unranked

8 citations

Ezra Golberstein, Bradley D. Stein, Johanna Catherine Maclean

Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009–2018

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.111290

N/A

0DataRank · unranked

4 citations

Andrew W. Dick, Adam J. Gordon, Brendan Saloner, Rose Kerber, Bradley D. Stein +1 more

High-Dose Opioid Prescribing in Individuals with Acute Pain: Assessing the Effects of US State Opioid Policies

Journal of General Internal Medicine(2024)10.1007/s11606-024-08947-9

N/A

0DataRank · unranked

4 citations

Thủy Nguyễn, Lucy Schulson, Andrew W. Dick, Justin Blackburn, Kosali Simon +2 more

Prescription Drug Dispensing and Patient Costs After Implementation of a No Behavioral Health Cost-Sharing Law

JAMA Health Forum(2024)10.1001/jamahealthforum.2024.0198

N/A

0DataRank · unranked

2 citations

James M. Campbell, Johanna Catherine Maclean, Samantha J. Harris, Brendan Saloner, Bradley D. Stein +1 more

Hospital Quality Indicators for Opioid-Exposed Infants: Results From an Expert Consensus Panel

PEDIATRICS(2024)10.1542/peds.2024-065721

N/A

0DataRank · unranked

1 citations

Bradley D. Stein, Sarah F. Loch, Scott A. Lorch, Stephen W. Patrick, Jordan M. Harrison

Implementation Of New Mexico’s ‘No Behavioral Health Cost Sharing’ Law: A Qualitative Study

Health Affairs(2024)10.1377/hlthaff.2024.00101

N/A

0DataRank · unranked

1 citations

Ezra Golberstein, Johanna Catherine Maclean, Bradley D. Stein, Susan L. Ettner, Brendan Saloner +1 more

Choosing an analytic approach: key study design considerations in state policy evaluation

Health Services and Outcomes Research Methodology(2025)10.1007/s10742-025-00369-2

N/A

0DataRank · unranked

2 citations

Megan S. Schuler, Elizabeth A. Stuart, Max Rubinstein, Max Griswold, Bradley D. Stein +2 more

The association of state policies and opioid analgesic amount dispensed from retail pharmacies

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2024.112533

N/A

0DataRank · unranked

1 citations

Flora Sheng, Erin Audrey Taylor, Corey S. Davis, Beth Ann Griffin, Mark Sorbero +2 more

Medications for opioid use disorder in traditional medicare beneficiaries: associations with age

Health Affairs Scholar(2025)10.1093/haschl/qxaf036

N/A

0DataRank · unranked

1 citations

Julie Lai, Jonathan Cantor, Denis Agniel, Kosali Simon, Bradley D. Stein +2 more

Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes

Journal of Addiction Medicine(2025)10.1097/adm.0000000000001573

N/A

0DataRank · unranked

1 citations

Flora Sheng, Bradley D. Stein, Rachel K. Landis

Teachers’ Reports of Attention-Deficit/Hyperactivity Disorder Medication Changes During Stimulant Shortages: National Survey Results

Journal of the American Academy of Child & Adolescent Psychiatry(2025)10.1016/j.jaac.2025.08.020

N/A

0DataRank · unranked

1 citations

Amy C Mahler, Rosanna Smart, Bradley D. Stein

Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.14045

N/A

0DataRank · unranked

69 citations

Jared Anderman, Travis Deseran, Ian S. Reynolds, Bradley D. Stein, Alexandra Duncan

Listings of Buprenorphine Offering by Substance Use Disorder Treatment Facilities and Waivered Clinician From July 2019 to May 2021

Journal of Addiction Medicine(2025)10.1097/adm.0000000000001439

Top 100%

0DataRank

Top 100%0 citations

Erin Audrey Taylor, Bradley D. Stein, Yuji Mizushima, Denis Agniel, Jonathan Cantor +1 more

Bradley D. Stein

Indexed papers

Top data-sharing exemplar

Papers